Nandrolone Decanoate

   
Google
 
Web NewDrugInformation.com

Nandrolone Decanoate


Drug - Nandrolone Decanoate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Nandrolone Decanoate
Multiple ingredients are in alphabetical order.

Strength - 50MG/ML
The potency of the active ingredient(s), Nandrolone Decanoate. May repeat for multiple part products.

Applicant - STERIS
The firm name holding legal responsibility for Nandrolone Decanoate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 087598
The FDA assigned number to Nandrolone Decanoate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Nandrolone Decanoate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 6, 1983
The date Nandrolone Decanoate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Nandrolone Decanoate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Nandrolone Decanoate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Steris Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Nandrolone Decanoate.

Nandrolone Decanoate